Concepedia

Joel Mane

JM

Statistics

Publications

7

Citations

154

H-Index

7

Active since

2016

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Joel Mane is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, glycemic control, and metabolic regulation.

Publications per year

2016–2024

7

Publications

7

GPR40 reduces food intake and body weight through GLP-1

Judith N. Gorski, Michele Pachanski, Joel Mane et al. · American Journal of Physiology-Endocrinology and Metabolism · 2017 · 41 citations · Full text

, , +17

Design and Synthesis of Novel, Selective GPR40 AgoPAMs

Christopher W. Plummer, Matthew J. Clements, Helen Chen et al. · ACS Medicinal Chemistry Letters · 2017 · 34 citations · Full text

, , +15

Discovery of benzofuran propanoic acid GPR120 agonists: From uHTS hit to mechanism-based pharmacodynamic effects

Matthew Lombardo, Kate Bender, Clare London et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 25 citations · Full text

, , +16

GPR40 partial agonists and AgoPAMs: Differentiating effects on glucose and hormonal secretions in the rodent

Michele Pachanski, Melissa Kirkland, Daniel Kosinski et al. · PLoS ONE · 2017 · 21 citations · Full text

, , +17

GPR40 partial agonist MK-2305 lower fasting glucose in the Goto Kakizaki rat via suppression of endogenous glucose production

Corin O. Miller, Michele Pachanski, Melissa Kirkland et al. · PLoS ONE · 2017 · 13 citations · Full text

, , +17

1–5 of 7